Frontiers in pediatrics · 2026
Comparative outcomes of interventional and surgical management of abdominal lymphatic cysts in children.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jiang Ying, Jiao Pan, Deng Ke-Heng, Zhou Jun, Huang Li-Li, Guo Zhaokun
Аннотация
OBJECTIVE: To investigate the efficacy of interventional and surgical treatment for pediatric abdominal lymphatic cysts (ALC), and provide evidence for the selection of clinical treatment strategies.
METHODS: A retrospective analysis was conducted on the clinical data of children with ALC from January 2015 to December 2025. The patients were divided into an interventional group and a surgical group according to the initial treatment modality. Baseline data were collected for all patients meeting the inclusion criteria, encompassing variables such as gender, age, weight, pre-treatment cyst size, clinical manifestations, cyst location, cyst type, treatment method, treatment efficacy, postoperative complications, and recurrence rate. These data were subsequently compared across different groups.
RESULTS: The present study included a total of 21 pediatric patients diagnosed with abdominal lymphangioma, comprising 12 males and 9 females, with a mean age of 6.33 ± 2.54 years. Participants were allocated into two groups based on their initial treatment: the intervention group (n = 9) and the operation group (n = 12). The follow-up period post-discharge ranged from 6 months to 10 years, with a median duration of 4.2 years. No significant differences were observed between the two groups concerning gender, age, weight, cyst size, cyst location, or cyst type (P > 0.05). However, the incidence of acute abdomen was significantly higher in the operation group compared to the intervention group (6 cases vs. 0 cases). There were no statistically significant differences in the incidence of postoperative complications or recurrence rates (P > 0.05). Conversely, the operation group exhibited a significantly higher treatment efficacy rate (100% vs. 66.7%), hospitalization costs (14,418 ± 2,031 yuan vs. 11,075 ± 1,309 yuan), and length of hospital stay (8.5 ± 2.2 days vs. 5.3 ± 1.6 days) compared to the intervention group, with these differences being statistically significant (P < 0.05).
CONCLUSIONS: Interventional therapy may serve as the primary treatment option for ALC, offering benefits such as minimal invasiveness, rapid recovery, and cost-effectiveness. Nevertheless, in the presence of complications like acute abdomen, surgical intervention is advised, with a preference for laparoscopic exploration.
METHODS: A retrospective analysis was conducted on the clinical data of children with ALC from January 2015 to December 2025. The patients were divided into an interventional group and a surgical group according to the initial treatment modality. Baseline data were collected for all patients meeting the inclusion criteria, encompassing variables such as gender, age, weight, pre-treatment cyst size, clinical manifestations, cyst location, cyst type, treatment method, treatment efficacy, postoperative complications, and recurrence rate. These data were subsequently compared across different groups.
RESULTS: The present study included a total of 21 pediatric patients diagnosed with abdominal lymphangioma, comprising 12 males and 9 females, with a mean age of 6.33 ± 2.54 years. Participants were allocated into two groups based on their initial treatment: the intervention group (n = 9) and the operation group (n = 12). The follow-up period post-discharge ranged from 6 months to 10 years, with a median duration of 4.2 years. No significant differences were observed between the two groups concerning gender, age, weight, cyst size, cyst location, or cyst type (P > 0.05). However, the incidence of acute abdomen was significantly higher in the operation group compared to the intervention group (6 cases vs. 0 cases). There were no statistically significant differences in the incidence of postoperative complications or recurrence rates (P > 0.05). Conversely, the operation group exhibited a significantly higher treatment efficacy rate (100% vs. 66.7%), hospitalization costs (14,418 ± 2,031 yuan vs. 11,075 ± 1,309 yuan), and length of hospital stay (8.5 ± 2.2 days vs. 5.3 ± 1.6 days) compared to the intervention group, with these differences being statistically significant (P < 0.05).
CONCLUSIONS: Interventional therapy may serve as the primary treatment option for ALC, offering benefits such as minimal invasiveness, rapid recovery, and cost-effectiveness. Nevertheless, in the presence of complications like acute abdomen, surgical intervention is advised, with a preference for laparoscopic exploration.